Position history for VANGUARD GROUP INC's holdings in AVADEL PHARMACEUTICALS PLC
VANGUARD GROUP INC holds 5.9M shares of AVDL (AVADEL PHARMACEUTICALS PLC), worth $126.4M as of 2025-Q4. The position was increased (++4.6% shares). AVDL represents 0.0% of VANGUARD GROUP INC's portfolio.
Current Value
$126.4M
Current Shares
5.9M
Total Value Change
+$75.7M
Total Shares Change
+2M
Other major holders of AVDL: ALLIANCEBERNSTEIN L.P., JANUS HENDERSON GROUP PLC, BlackRock, Inc.
Increased |
| 5.9M |
+4.6% |
| $126.4M |
| 0.0% |
| $21.54 |
32 |
| 2025-Q3 | Increased | 5.6M | +0.8% | $85.6M | 0.0% | $15.31 | 30 |
| 2025-Q2 | Increased | 5.6M | +42.5% | $49.2M | 0.0% | $9.20 | 39 |
| 2025-Q1 | Decreased | 3.9M | -1.2% | $30.6M | 0.0% | $8.01 | 0 |
| 2024-Q4 | Increased | 4M | +2.3% | $41.5M | 0.0% | $10.50 | 30 |
| 2024-Q3 | New | 3.9M | - | $50.7M | 0.0% | $12.75 | 41 |